Acurx Pharmaceuticals Llc Stock Pattern Recognition Piercing Pattern
| ACXP Stock | USD 2.73 0.77 39.29% |
| Symbol |
Recognition |
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was eleven with a total number of output elements of fifty. The function did not return any valid pattern recognition events for the selected time horizon. The Piercing pattern may indicate Acurx Pharmaceuticals low bullish reversal trend.
Acurx Pharmaceuticals Technical Analysis Modules
Most technical analysis of Acurx Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Acurx from various momentum indicators to cycle indicators. When you analyze Acurx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Acurx Pharmaceuticals LLC Enterprise and Market Value
Acurx Pharmaceuticals is a micro-cap equity in Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care categories. Valuation integrates earnings durability and capital efficiency. Market-sensitive characteristics amplify cycle exposure. We evaluate Acurx Pharmaceuticals through the lens of long-term portfolio construction and diversification efficiency.
Methodology
Unless otherwise specified, financial data for Acurx Pharmaceuticals LLC is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Acurx (USA Stocks:ACXP) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions Valuation estimates and intrinsic-value models use inputs from public financial disclosures and may not represent market consensus.
Assumptions
We primarily rely on public filings and market reference sources, including disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Data is normalized for analytical consistency across reporting formats. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.Analyst Sources
Acurx Pharmaceuticals LLC may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Acurx Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Acurx Pharmaceuticals' short interest history, or implied volatility extrapolated from Acurx Pharmaceuticals options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.![]() | Momentum Invested over 20 shares | |
![]() | Chemicals Makers Invested over 60 shares | |
![]() | Macroaxis Index Invested few shares | |
![]() | Investor Favorites Invested over 200 shares | |
![]() | Warren Buffett Holdings Invested few shares | |
![]() | Artificial Intelligence Invested few shares | |
![]() | FinTech Invested over 60 shares | |
![]() | Baby Boomer Prospects Invested over 20 shares | |
![]() | Synthetics Invested over 70 shares | |
![]() | Driverless Cars Invested few shares |
Additional Tools for Acurx Stock Analysis
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |









